Petros Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,576 | $1,421 | $1,388 | $-364 |
Gross Profit | 1,289 | 1,092 | 1,056 | -522 |
EBITDA | -1,293 | 207 | -1,288 | |
EBIT | -2,061 | -547 | -2,042 | |
Net Income | -2,220 | -662 | -8,026 | 318 |
Net Change In Cash | 1,576 | 1,421 | 1,388 | -364 |
Free Cash Flow | -790 | -1,662 | -1,134 | -2,259 |
Cash | 3,894 | 7,460 | 11,080 | 13,336 |
Basic Shares | 9,829 | 7,388 | 4,756 | 2,991 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $5,822 | $5,992 | $7,811 | $9,559 |
Gross Profit | 4,191 | 3,702 | 6,211 | 5,513 |
EBITDA | -4,211 | -13,725 | -1,636 | -12,208 |
EBIT | -7,627 | -19,441 | -8,618 | -18,962 |
Net Income | -8,163 | -27,037 | -9,355 | -20,585 |
Net Change In Cash | 5,822 | 5,992 | 7,811 | 9,559 |
Free Cash Flow | -7,626 | -12,797 | -11,862 | -15,309 |
Cash | 13,336 | 9,426 | 23,847 | 17,139 |
Basic Shares | 2,176 | 2,070 | 1,088 | 970 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.53 |
2024-06-30 | -$0.37 |
2024-03-31 | -$1.69 |
2023-12-31 | -$2.17 |
